The Democrats have been in control of Washington for almost nine months now, and all they have to show for it is keeping Governor Gavin Newsom of California in office. Other than that, there is nothing but disaster after disaster surrounding the Democratic Party and President Joe Biden.
Although it’s obvious that they are at odds with the Republicans, apparently, the Democrats can’t even agree among themselves when it comes to something as simple as prescription drug plans.
Schrader, Peters AND now Rice all opposed the drug price negotiation measure.
That's enough Dems to sink it. Vote still ongoing. https://t.co/rpuo6wSAS9
— Sarah Ferris (@sarahnferris) September 15, 2021
MORE NEWS: Are We Supplicants Or Americans?
For some time now, House Speaker Nancy Pelosi has been pushing legislation that would ultimately lower drug prices, as they claim. But this week, when the matter was voted on, the Democrat-backed legislation was buried by three Democrats who voted against it.
Representatives Scott Peters of California, Kathleen Rice of New York, and Kurt Schrader of Oregon all voted against the plan to allow officials to start negotiating lower prices on prescription drugs. But while the Democrats claim the legislation was for the people, it should be noted that Pelosi was also using the matter to try and help push Biden’s $3.5 trillion spending bill through Congress.
After the embarrassing defeat by her own party, Pelosi decided not to speak with the press. Although her spokesperson Henry Connelly did release a statement saying, “Polling consistently shows immense bipartisan support for Democrats’ drug price negotiation legislation, including overwhelming majorities of Republicans and independents who are fed up with Big Pharma charging Americans so much more than they charge for the same medicines overseas. Delivering lower drug costs is a top priority of the American people and will remain a cornerstone of the Build Back Better Act as work continues between the House, Senate, and White House on the final bill.”
As for the three defiant Democrats, many liberals voiced their opinions on the matter, including Patrick Gaspard, the Center for American Progress president. “Reps. Peters, Rice, and Schrader are prioritizing drug company profits over lower drug prices for the American people, particularly for patients with chronic conditions such as diabetes and multiple sclerosis. To the contrary of what they contend, their opposition to the drug’s proposal threatens the entirety of President Joe Biden’s Build Back Better agenda, which Democrats have campaigned on for years and that they previously voted for.”